Căutare

ilabsci

2026-02-25 05:46:18 ·Translate ·

Advanced Biotechnology Instruments for Modern Life Science Laboratories

Biotechnology instruments play a vital role in advancing molecular biology, genomics, proteomics, cell culture, diagnostics, and bio manufacturing. From PCR and real-time PCR to protein analysis, fermentation monitoring, and ELISA workflows, precision and reproducibility are essential. ILAB offers a comprehensive range of biotechnology instruments, including micro plate readers, bioreactors, gel documentation systems, incubators, centrifuges, spectrometers, automated pipetting workstations, and thermal cyclers.

https://www.ilabsci.com/products.php

Advanced Biotechnology Instruments for Modern Life Science Laboratories Biotechnology instruments play a vital role in advancing molecular biology, genomics, proteomics, cell culture, diagnostics, and bio manufacturing. From PCR and real-time PCR to protein analysis, fermentation monitoring, and ELISA workflows, precision and reproducibility are essential. ILAB offers a comprehensive range of biotechnology instruments, including micro plate readers, bioreactors, gel documentation systems, incubators, centrifuges, spectrometers, automated pipetting workstations, and thermal cyclers. https://www.ilabsci.com/products.php

·3K Views ·0 previzualizare

Vă rugăm să vă autentificați pentru a vă dori, partaja și comenta!
kunalchandgude a adăugat o fotografie

2025-11-17 09:49:37 ·Translate ·

Global ODPA Market to Reach USD 92.8 Million by 2029, 10.6% CAGR from USD 45.2 Million in 2022

The global 4-Nitrophenyl Chloroformate market, valued at USD 84.3 million in 2024, is forecast to grow at 5.8% CAGR to USD 132.5 million by 2032. Driven by rising demand in pharmaceutical synthesis, bioconjugation, proteomics, and oligonucleotide therapeutics, high-purity grades dominate amid strong North American and European adoption.

Get Full Report Here: https://www.24chemicalresearch.com/reports/204588/global-oxydiphthalic-anhydride-forecast-market-2023-2029-170

Global ODPA Market to Reach USD 92.8 Million by 2029, 10.6% CAGR from USD 45.2 Million in 2022 The global 4-Nitrophenyl Chloroformate market, valued at USD 84.3 million in 2024, is forecast to grow at 5.8% CAGR to USD 132.5 million by 2032. Driven by rising demand in pharmaceutical synthesis, bioconjugation, proteomics, and oligonucleotide therapeutics, high-purity grades dominate amid strong North American and European adoption. Get Full Report Here: https://www.24chemicalresearch.com/reports/204588/global-oxydiphthalic-anhydride-forecast-market-2023-2029-170

·2K Views ·0 previzualizare

Vă rugăm să vă autentificați pentru a vă dori, partaja și comenta!
kunalchandgude a adăugat o fotografie

2025-11-17 09:26:08 ·Translate ·

Global 4-Nitrophenyl Chloroformate Market to Reach USD 132.5 Million by 2032, 5.8% CAGR from USD 84.3 Million in 2024

The global 4-Nitrophenyl Chloroformate market, valued at USD 84.3 million in 2024, is forecast to grow at 5.8% CAGR to USD 132.5 million by 2032. Driven by rising demand in pharmaceutical synthesis, bioconjugation, proteomics, and oligonucleotide therapeutics, high-purity grades dominate amid strong North American and European adoption.

Get Full Report Here: https://www.24chemicalresearch.com/reports/204744/global-nitrophenyl-chloroformate-forecast-market-2023-2029-998

Global 4-Nitrophenyl Chloroformate Market to Reach USD 132.5 Million by 2032, 5.8% CAGR from USD 84.3 Million in 2024 The global 4-Nitrophenyl Chloroformate market, valued at USD 84.3 million in 2024, is forecast to grow at 5.8% CAGR to USD 132.5 million by 2032. Driven by rising demand in pharmaceutical synthesis, bioconjugation, proteomics, and oligonucleotide therapeutics, high-purity grades dominate amid strong North American and European adoption. Get Full Report Here: https://www.24chemicalresearch.com/reports/204744/global-nitrophenyl-chloroformate-forecast-market-2023-2029-998

·1K Views ·0 previzualizare

Vă rugăm să vă autentificați pentru a vă dori, partaja și comenta!
vamshee PRO A distribuit un link

2024-06-20 11:28:18 ·Translate ·

The report "Prostate Cancer Diagnostic Market By Test Type (Tumor Biomarker Tests, Imaging, Biopsy, Other) By Cancer Stage (Stage I, Stage II A, Stage II B, Stage III, Stage IV), By End User (Hospital Associated Labs, Independent Diagnostic Labs, Diagnostic Imaging Centers, Cancer Research Institutes, Others) - Global Forecasts to 2030"

The global prostate cancer diagnostic market is projected to reach USD 126.5 billion in 2023, registering a Compound Annual Growth Rate (CAGR) of 8.6% during the forecast period 2024-2030. The growth of the market is majorly driven by the innovation in drugs and developments in genomics and proteomics

Request sample report at https://www.precisionbusinessinsights.com/request-sample/?product_id=22416

Competitive Dashboard:
The prominent key players operating in the global prostate cancer diagnostic market are Accuquik Test Kits (U.S.), ACON Laboratories, Inc. (U.S.), bioMérieux SA (France), HUMASIS (South Korea), Teco Diagnostics (U.S.), Hologic Inc. (U.S.), MDxHealthcare (Belgium), Abbott (U.S.), Siemens Healthcare GmbH (Germany), OPKO Health Inc. (U.S.), Myriad Genetics, Inc. (U.S.), DiaSorin S.p.A (Italy), Beckman Coulter, Inc. (a subsidiary of Danaher) (U.S.), Metamark Genetics, Inc. (U.S.), Prostatype Genomics (Switzerland), Fujirebio (Belgium), Proteomedix (Switzerland), Eurolyser Diagnostica GmbH (Austria), F. Hoffmann-La Roche Ltd (Switzerland)

The report "Prostate Cancer Diagnostic Market By Test Type (Tumor Biomarker Tests, Imaging, Biopsy, Other) By Cancer Stage (Stage I, Stage II A, Stage II B, Stage III, Stage IV), By End User (Hospital Associated Labs, Independent Diagnostic Labs, Diagnostic Imaging Centers, Cancer Research Institutes, Others) - Global Forecasts to 2030" The global prostate cancer diagnostic market is projected to reach USD 126.5 billion in 2023, registering a Compound Annual Growth Rate (CAGR) of 8.6% during the forecast period 2024-2030. The growth of the market is majorly driven by the innovation in drugs and developments in genomics and proteomics Request sample report at https://www.precisionbusinessinsights.com/request-sample/?product_id=22416 Competitive Dashboard: The prominent key players operating in the global prostate cancer diagnostic market are Accuquik Test Kits (U.S.), ACON Laboratories, Inc. (U.S.), bioMérieux SA (France), HUMASIS (South Korea), Teco Diagnostics (U.S.), Hologic Inc. (U.S.), MDxHealthcare (Belgium), Abbott (U.S.), Siemens Healthcare GmbH (Germany), OPKO Health Inc. (U.S.), Myriad Genetics, Inc. (U.S.), DiaSorin S.p.A (Italy), Beckman Coulter, Inc. (a subsidiary of Danaher) (U.S.), Metamark Genetics, Inc. (U.S.), Prostatype Genomics (Switzerland), Fujirebio (Belgium), Proteomedix (Switzerland), Eurolyser Diagnostica GmbH (Austria), F. Hoffmann-La Roche Ltd (Switzerland)

WWW.PRECISIONBUSINESSINSIGHTS.COM

Request Sample

Request Sample

·6K Views ·0 previzualizare

Vă rugăm să vă autentificați pentru a vă dori, partaja și comenta!

Conecteaza-te

Limbi

Request Sample